Global Diabetic Care Market to grow over $122 billion by 2022

BLOOMINGTON, Minn. - Dec. 28, 2015 - PRLog -- With the advancement of drug delivery technologies and blood glucose diagnostic devices, the diabetic care market has emerged as a rapidly developing sector in healthcare. The market growth is gaining speed as large number of government initiatives and research & development programs has been launched in the recent years. The legal approval of the artificial pancreas or  high level of advancement in cell therapy such as islet cell transplant, stem cell transplant, among others are foreseen as viable opportunities in diabetic care management.

According to the report titled “Global Diabetic Care Market” report put forward by the market research experts of BIS Research, the global diabetic care market is expected to grow approximately over $122 billion by 2022 at an estimated CAGR of 9.23% from 2015 to 2022. While the Americas have dominated the global market in 2014, Europe will continue to be the leading revenue generating region of the world. Patient monitoring will continue to be the largest revenue generating end-use application. Gestational diabetes cases are growing with a CAGR of 11.13% from 2015 to 2022.

Rapid demand of Self Monitoring Blood Glucose Monitors (SMBG), Continuous Glucose Monitors and Insulin pumps, modern insulin and mobile applications have compelled the big market players to take initiatives which are focused towards expanding research and development programs to develop better prevention and treatment methods in short term scenarios.

The 261 pages report with over 152 market figures and 12 data tables is a compilation of different peripherals of the Global Diabetic Care Market including market divisions by ecosystem, by diabetes types, by end-use applications, and by geography. Herein the revenue generated from each segment, application and region is tracked to compute the market size.

The report also includes porter’s five forces analysis, value chain analysis, market dynamics, key consortiums, compliances, and regulatory bodies surrounding the Global Diabetic Care market. Due to the diverse ecosystem of this market, a separate section has been incorporated in the report for the key strategies and development activities undertaken by the key market players including drug manufacturers, device manufacturers and mobile application developers. The key players are also profiled in detail.

An analyst at BIS Research believes that North America is holding the maximum market share and is expected to grow at 6.35% CAGR from 2015 to 2022. Observing current trends, many big companies are collaborating and entering into partnerships with healthcare providers, academic institutions, pharmaceuticals and biotechnology companies to support the growth of the diabetic care market.

The key companies profiled in the report are Eli Lilly and Company, Novo Nordisk, AstraZeneca, Merck & Co., Inc., Bristol-Myers-Squibb Company, Boehringer Ingelheim group, Roche Holdings, Pfizer Inc., Sanofi Pharma, Novartis, GSK, Johnson & Johnson, and Abbott Laboratories among others.

The answers to the following key questions can be found in the report:

·         What are the major market drivers, challenges and opportunities of the diabetic care market and their use cases?

·         What are the key trends and developments in the diabetic care market for different diabetic care management?

·         What are the key developmental strategies in different applications across all regions?

·         What are different types of diabetic care solutions and the latest diabetic care technologies?

·         How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launches among others?

·         Which geographical region will lead the global diabetic care market by the end of the forecast period?

·         Who are the key players in the diabetic care market?

·         What are the key government regulations for different diabetic care solutions?

·         What are different types of devices, drugs and mobile applications in diabetic care market and what are the applications in which they are being used?

·         What are the different end-use applications in which diabetic care products are being used?

·         What is the different used case scenarios considered under different end-use applications?

·         What are the diabetic care market trends and key developments in different geographical regions?

About BIS Research(http://bisresearch.com/diabetic-care-devices-market-resea...):

BIS Research publishes in-depth market intelligence reports focusing on the market estimations, technology analysis, evolving high-growth applications, deeply segregated granular country-level market data and other important market parameters useful in the decision making for senior management. It provides multi-client reports, company profiles, databases, syndicate and custom research services.

BIS Research provides valuable market intelligence to an exclusive group of customers in response to orders. Market reports are based on expectations, calculations and projections as of the date such information is available. The market conclusions drawn are based upon a number of estimates and assumptions that, while considered reasonable by BIS Research as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies.